RxDoctor Payments Data

Tania Harvey

Psychiatric/Mental Health · Ocala, FLNPI 1295445914

Payments from drug & device makers

$2,268in general payments, 2019–2025

Across 105 payments — averaging $21.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$1K
  • Neurocrine Biosciences, Inc.$368
  • Acadia Pharmaceuticals Inc$270
  • Otsuka America Pharmaceutical, Inc.$239

What the payments were for

  • Food & beverage$2,07391%
  • Education$1959%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,268 in reported general payments places this provider in the 75th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida

Medicare billing

Part B allowed, 2024
$151,263
Medicare patients
599
Services billed
1,704

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine34$263,712
NuedextaDextromethorphan Hbr/Quinidine192$253,474
Austedo XrDeutetrabenazine37$211,495
NuplazidPimavanserin Tartrate26$141,194
IngrezzaValbenazine Tosylate25$127,507
Invega SustennaPaliperidone Palmitate15$42,267
RexultiBrexpiprazole23$22,673
Trazodone Hcl987$19,215
Divalproex Sodium274$13,150
Oxcarbazepine97$8,170
Sertraline Hcl342$6,341
EliquisApixaban20$5,527
Doxepin Hcl15$4,310
Mirtazapine88$4,100
Aripiprazole16$3,618

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo, Austedo Xr$1,391$475,20771 claims
Acadia Pharmaceuticals IncNuplazid$270$141,19426 claims
Neurocrine Biosciences, Inc.Ingrezza$368$127,50725 claims
Otsuka America Pharmaceutical, Inc.Rexulti$239$22,67323 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,096 psychiatric/mental health providers in Florida.

Other psychiatric/mental health in Ocala

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →